Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction
Stephen J. Greene(Duke Medical Center), Gregg C. Fonarow(UCLA Medical Center), Adrian F. Hernandez(Duke University), John A. Spertus(Saint Luke's Health System), Javed Butler(Jackson Memorial Hospital), Laine Thomas(Duke University), Muthiah Vaduganathan(Brigham and Women's Hospital), Fredonia B. Williams(Heartsong), Nancy M. Albert(Cleveland Clinic), Adam D. DeVore(Duke University), Carol I. Duffy(Novartis (United States)), J. Herbert Patterson(University of North Carolina at Chapel Hill), Anne S. Hellkamp(Clinical Research Institute)
Cited by 153
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Journal of Heart Failure|2022|2.1k